BLAIR WILLIAM & CO/IL - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$180,519
-1.5%
11,6690.0%0.00%0.0%
Q2 2023$183,320
-5.1%
11,669
-0.5%
0.00%0.0%
Q1 2023$193,220
+5.1%
11,724
-0.5%
0.00%0.0%
Q4 2022$183,760
+20.1%
11,779
+0.0%
0.00%0.0%
Q3 2022$153,000
-0.6%
11,776
+7.1%
0.00%0.0%
Q2 2022$154,000
-10.5%
10,994
-8.6%
0.00%0.0%
Q1 2022$172,000
+8.2%
12,025
+3.4%
0.00%
Q4 2021$159,000
-25.0%
11,635
-10.0%
0.00%
-100.0%
Q3 2021$212,000
-1.9%
12,922
+0.7%
0.00%0.0%
Q2 2021$216,000
-10.7%
12,826
-3.2%
0.00%0.0%
Q1 2021$242,000
+3.0%
13,249
+2.6%
0.00%0.0%
Q4 2020$235,000
-8.2%
12,913
-10.1%
0.00%0.0%
Q3 2020$256,000
-4.1%
14,358
-3.6%
0.00%0.0%
Q2 2020$267,000
+25.4%
14,892
+6.3%
0.00%0.0%
Q1 2020$213,000
-19.9%
14,012
+3.9%
0.00%0.0%
Q4 2019$266,000
-9.2%
13,488
-20.9%
0.00%
-50.0%
Q3 2019$293,000
+7.7%
17,044
+10.8%
0.00%0.0%
Q2 2019$272,000
-17.6%
15,384
-5.0%
0.00%0.0%
Q1 2019$330,00016,1900.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders